Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

NVAX:US

8.8900 USD 0.0200 0.23%

As of 20:10:00 ET on 05/26/2015.

Snapshot for Novavax Inc (NVAX)

Open: 8.8300 Day's Range: 8.7700 - 8.9200 Volume: 1,577,193
Previous Close: 8.8700 52wk Range: 3.9200 - 9.9500 1-Yr Rtn: +73.29%

Stock Chart for NVAX

No chart data available.
  • NVAX:US 8.9000
  • 1D
  • 1M
  • 1Y
8.8700
Interactive NVAX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for NVAX

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.3900
Est. EPS (USD) (12/2015) -0.4400
Est. PEG Ratio -
Market Cap (M USD) 2,382.79
Shares Outstanding (M) 268.03
30 Day Average Volume 3,090,409
Price/Book (mrq) 5.9590
Price/Sale (ttm) 62.7677
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/06/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for NVAX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for NVAX

Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.

Stanley C ErckPresident/CEOBarclay A Phillips "Buck"Senior VP/CFO/Treasurer
John A Herrmann IIISenior VP/Secy/Gen CnslRussell P Wilson "Rip"Senior VP:Business Development
More Company Profile & Key Executives for NVAX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil